[go: up one dir, main page]

CL2017002549A1 - Use of a bismuth-thiol (bt) composition, which is used to prepare a medication useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection. - Google Patents

Use of a bismuth-thiol (bt) composition, which is used to prepare a medication useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection.

Info

Publication number
CL2017002549A1
CL2017002549A1 CL2017002549A CL2017002549A CL2017002549A1 CL 2017002549 A1 CL2017002549 A1 CL 2017002549A1 CL 2017002549 A CL2017002549 A CL 2017002549A CL 2017002549 A CL2017002549 A CL 2017002549A CL 2017002549 A1 CL2017002549 A1 CL 2017002549A1
Authority
CL
Chile
Prior art keywords
composition
bismuth
thiol
risk
prepare
Prior art date
Application number
CL2017002549A
Other languages
Spanish (es)
Inventor
Brett Hugh James Baker
Original Assignee
Microbion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/023549 external-priority patent/WO2011097347A2/en
Application filed by Microbion Corp filed Critical Microbion Corp
Publication of CL2017002549A1 publication Critical patent/CL2017002549A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
    • A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

<p>la invención divulga uso de una composición de bismuto-tiol (BT), CARACTERIZADO porque sirve para preparar un medicamento útil para el tratamiento de una herida abierta que tiene o que está en riesgo de tener una infección de biopelícula bacteriana, en donde la composición BT comprende una suspensión monodispersa de micropartículas que comprenden un compuesto de BT, en donde en dicha suspensión, al menos el 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% o 99% de dichas micropartículas tienen un diámetro volumétrico medio de aproximadamente 0,4 μm a aproximadamente 10μm.</p><p> The invention discloses the use of a bismuth-thiol (BT) composition, CHARACTERIZED because it serves to prepare a medicament useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection, wherein The BT composition comprises a monodispersed suspension of microparticles comprising a BT compound, wherein in said suspension, at least 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96 %, 97%, 98% or 99% of said microparticles have an average volumetric diameter of about 0.4 µm to about 10μm. </p>

CL2017002549A 2010-08-12 2017-10-10 Use of a bismuth-thiol (bt) composition, which is used to prepare a medication useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection. CL2017002549A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37318810P 2010-08-12 2010-08-12
PCT/US2011/023549 WO2011097347A2 (en) 2010-02-03 2011-02-03 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses

Publications (1)

Publication Number Publication Date
CL2017002549A1 true CL2017002549A1 (en) 2018-05-11

Family

ID=44356067

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2013000430A CL2013000430A1 (en) 2010-08-12 2013-02-12 Method to protect a plant against a bacterial, fungal or viral pathogen because it comprises contacting the plant with bismuth thiol (bt); method for overcoming antibiotic resistance in a plant, in or on which a bacterial plant pathogen resistant to antibiotics is present.
CL2017002549A CL2017002549A1 (en) 2010-08-12 2017-10-10 Use of a bismuth-thiol (bt) composition, which is used to prepare a medication useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2013000430A CL2013000430A1 (en) 2010-08-12 2013-02-12 Method to protect a plant against a bacterial, fungal or viral pathogen because it comprises contacting the plant with bismuth thiol (bt); method for overcoming antibiotic resistance in a plant, in or on which a bacterial plant pathogen resistant to antibiotics is present.

Country Status (17)

Country Link
EP (1) EP2603083A4 (en)
JP (7) JP2013535506A (en)
KR (6) KR101821833B1 (en)
CN (2) CN103096720B (en)
AU (3) AU2011289338B2 (en)
BR (2) BR112012019286A2 (en)
CA (1) CA2807993C (en)
CL (2) CL2013000430A1 (en)
IL (3) IL224684A (en)
MX (4) MX371047B (en)
NZ (1) NZ606634A (en)
PH (2) PH12013500267A1 (en)
RU (2) RU2018108411A (en)
SG (3) SG187801A1 (en)
UA (1) UA113616C2 (en)
WO (1) WO2012021754A2 (en)
ZA (1) ZA201301841B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
US8389021B2 (en) 2009-02-03 2013-03-05 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
KR101821833B1 (en) * 2010-02-03 2018-01-25 마이크로비온 코포레이션 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
JP6392846B2 (en) * 2013-03-18 2018-09-19 テラノーヴィス・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンディトゲゼルシャフト Oral care composition
RU2525200C1 (en) * 2013-04-09 2014-08-10 Алексей Георгиевич Бородкин Agent for protection and repair of wound of trees
KR101703732B1 (en) * 2013-11-07 2017-02-07 (주)아모레퍼시픽 Anti-inflammatory composition containing enzymated camellia japonica seed oil
WO2017145142A1 (en) 2016-02-25 2017-08-31 Nobio Ltd. Micro and nanoparticulate compositions comprising anti-microbially active groups
BR112020004156A2 (en) 2017-08-30 2020-09-08 Nobio Ltd. antimicrobial particles and methods of applying them
CN107950536A (en) * 2017-12-04 2018-04-24 刘志伟 A kind of bactericidal composition containing Bravo
CN108839186B (en) * 2018-05-15 2021-02-26 阜南县金威工艺品有限公司 Mildew-proof treatment method for mulberry twig woven product
MX2021001276A (en) 2018-07-31 2021-07-15 Microbion Corp Bismuth-thiol compositions and methods for treating wounds.
MX2021001272A (en) 2018-07-31 2021-07-15 Microbion Corp Bismuth-thiol compositions and methods of use.
KR101990253B1 (en) * 2018-11-22 2019-06-17 하봉호 Container type mushroom growing apparatus
CN109997856B (en) * 2019-04-15 2020-11-03 广西大学 Composition of small molecular compound and application thereof
US20230240305A1 (en) * 2019-06-17 2023-08-03 Migal Galilee Research Institute Ltd. Stabilized mutants of quorum quenching lactonase and use thereof in treatment of pathogens
KR102126721B1 (en) * 2019-07-16 2020-06-25 (주)인트론바이오테크놀로지 Novel Enterobacter aerogenes bacteriophage Ent-AEP-1 and its use for preventing proliferation of Enterobacter aerogenes and Enterobacter cloacae
JP7458622B2 (en) * 2019-09-18 2024-04-01 学校法人東京農業大学 Substances that reduce the resistance of antibiotic-resistant microorganisms and methods for reducing the resistance of antibiotic-resistant microorganisms
CN110663672B (en) * 2019-11-13 2024-04-26 南京林业大学 Thread-driven root pesticide application head
US11479655B2 (en) * 2020-01-15 2022-10-25 The Boeing Company Compositions for use with polysulfide sealants and related methods
KR102197719B1 (en) 2020-05-07 2021-01-04 곽태진 Cuttlefish breeding system
CN111856546B (en) * 2020-06-23 2022-07-29 中国辐射防护研究院 Sample preparation method for radiochemical analysis of Cs-137 in marine organism ash
CN113969300B (en) * 2020-07-23 2024-08-23 禾美生物科技(浙江)有限公司 Eucalyptus leaf composite active extract process and antibacterial application thereof
CN112640907B (en) * 2021-01-19 2021-11-16 西南大学 New application of lipoic acid for inhibiting plant fungal pathogens and method for preventing and controlling postharvest fungal diseases of citrus fruits
KR102431000B1 (en) * 2021-07-22 2022-08-11 농업회사법인 주식회사 아그로비즈 Composition for an autoimmune builder of plants containing aspirin and benzothiazole, and method of using the same
WO2023180932A1 (en) * 2022-03-22 2023-09-28 Oro Agri Europe, S.A. Agricultural composition
EP4310192A1 (en) * 2022-07-21 2024-01-24 C4Diagnostics Method of determining the existence and/or degree of resistance of microorganisms to antimicrobial agents
CN115323778B (en) * 2022-08-16 2023-07-18 汕头市润丰纺织科技实业有限公司 Chitosan-I type collagen amino acid composite antibacterial finishing liquid, preparation method thereof and antibacterial fabric
TR2022012983A2 (en) * 2022-08-17 2022-09-21 Marmara Ueniv Strateji Gelis Dai Bsk Muhasebe Birimi A BIOCOMPATIBLE PRODUCT WITH REPRESENTATIVE AND THERAPEUTIC PROPERTIES FOR BONE DISORDERS AND/OR FRACTURES AND A METHOD FOR OBTAINING THE SUBJECT PRODUCT
CN115532295B (en) * 2022-09-27 2023-07-25 苏州大学 Application of Nanomaterials Containing Zn-N-C Active Centers in Removal of Bacterial Biofilms
KR102644907B1 (en) * 2023-12-01 2024-03-07 (주)신용이엔씨 Eco-friendly grouting composition for ground reinforcement and method of manufacturing the same

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809971A (en) * 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
JP3813644B2 (en) * 1994-08-29 2006-08-23 英治 安里 Bismuth complex and antibacterial agent containing the same
US6086921A (en) * 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
US5928671A (en) * 1995-04-25 1999-07-27 Winthrop University Hospital Method and composition for inhibiting bacteria
US6017936A (en) * 1997-03-14 2000-01-25 Arch Chemicals, Inc. Method for producing particles of pyrithione salts and particles so produced
US5999828A (en) * 1997-03-19 1999-12-07 Qualcomm Incorporated Multi-user wireless telephone having dual echo cancellers
AU2003204105B2 (en) * 1997-10-28 2005-11-17 Winthrop-University Hospital Metal/Thiol Biocides
AU2656799A (en) * 1998-02-04 1999-08-23 Winthrop-University Hospital Metal-thiols as imminomodulating agents
US6465015B1 (en) * 1998-02-24 2002-10-15 Arch Chemicals, Inc. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
TWI245763B (en) * 1998-04-02 2005-12-21 Janssen Pharmaceutica Nv Biocidal benzylbiphenyl derivatives
WO2000016624A1 (en) * 1998-09-23 2000-03-30 Phycogen, Inc. Safe and effective biofilm inhibitory compounds and health-related uses thereof
US6682724B2 (en) * 1999-02-23 2004-01-27 Arch Chemcials, Inc. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
US6630172B2 (en) * 2001-01-22 2003-10-07 Kareem I. Batarseh Microbicidal composition containing potassium sodium tartrate
US6582719B2 (en) * 2001-02-02 2003-06-24 The Trustees Of Columbia University In The City Of New York Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms
JP4357166B2 (en) * 2002-10-21 2009-11-04 日揮触媒化成株式会社 Antibacterial / antifungal / algae-proof composition
WO2008043175A1 (en) * 2006-10-13 2008-04-17 Kane Biotech Inc. SOLUBLE β-N-ACETYLGLUCOSAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF
US7381751B2 (en) * 2003-08-26 2008-06-03 Shantha Sarangapani Antimicrobial composition for medical articles
WO2006046155A2 (en) * 2004-10-25 2006-05-04 Polyzenix Gmbh Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
JP4568232B2 (en) * 2006-01-06 2010-10-27 秀和 西松 Artificial bone head holder
JP2007332040A (en) * 2006-06-12 2007-12-27 Shinshu Univ Antibacterial agent containing carbon nanotube, and material and preparation using the same
AU2008207864B2 (en) * 2007-01-24 2013-07-11 Cook Biotech Incorporated Biofilm-inhibiting medical products
US8343536B2 (en) 2007-01-25 2013-01-01 Cook Biotech Incorporated Biofilm-inhibiting medical products
EP2497364A1 (en) * 2007-05-18 2012-09-12 Sciessent, LLC Bioactive agrichemical compositions and their use
US8895047B2 (en) * 2007-06-01 2014-11-25 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
CN101820861A (en) * 2007-07-25 2010-09-01 西洛诺瓦生物科学公司 Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US8389021B2 (en) 2009-02-03 2013-03-05 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
KR101821833B1 (en) * 2010-02-03 2018-01-25 마이크로비온 코포레이션 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses

Also Published As

Publication number Publication date
NZ606634A (en) 2015-01-30
JP2020063277A (en) 2020-04-23
BR112012019286A2 (en) 2018-06-26
MX2019001293A (en) 2019-07-04
IL258908A (en) 2018-06-28
WO2012021754A2 (en) 2012-02-16
CN105766990A (en) 2016-07-20
PH12016502498A1 (en) 2018-06-11
SG10201506131RA (en) 2015-09-29
CN103096720A (en) 2013-05-08
MX371047B (en) 2020-01-14
SG187801A1 (en) 2013-03-28
PH12013500267A1 (en) 2017-07-19
JP2022003090A (en) 2022-01-11
MX395247B (en) 2025-03-25
AU2016203475A1 (en) 2016-06-16
RU2018108411A (en) 2019-02-25
KR20200015814A (en) 2020-02-12
AU2018204190B2 (en) 2020-07-23
MX2013001581A (en) 2013-03-20
JP6685991B2 (en) 2020-04-22
KR102074444B1 (en) 2020-02-06
MX2019010863A (en) 2019-11-05
KR20180085042A (en) 2018-07-25
BR112013003127A2 (en) 2016-06-28
CL2013000430A1 (en) 2013-10-04
EP2603083A4 (en) 2014-10-22
CN105766990B (en) 2019-08-02
EP2603083A2 (en) 2013-06-19
JP6272366B2 (en) 2018-01-31
JP2018076358A (en) 2018-05-17
SG10202001032RA (en) 2020-04-29
AU2011289338A1 (en) 2013-03-28
KR20130000386A (en) 2013-01-02
KR20130132410A (en) 2013-12-04
JP7097344B2 (en) 2022-07-07
IL248446B (en) 2018-05-31
KR101966867B1 (en) 2019-04-08
ZA201301841B (en) 2024-10-30
WO2012021754A3 (en) 2012-05-24
KR101821833B1 (en) 2018-01-25
CN103096720B (en) 2016-03-30
AU2018204190A1 (en) 2018-07-05
JP2018008971A (en) 2018-01-18
MX362785B (en) 2019-02-12
CA2807993C (en) 2023-03-14
RU2013110493A (en) 2014-09-20
JP2013535506A (en) 2013-09-12
JP2020055839A (en) 2020-04-09
KR20190039607A (en) 2019-04-12
UA113616C2 (en) 2017-02-27
AU2011289338B2 (en) 2015-01-22
IL224684A (en) 2016-11-30
JP2016117741A (en) 2016-06-30
CA2807993A1 (en) 2012-02-16
KR20170136009A (en) 2017-12-08

Similar Documents

Publication Publication Date Title
CL2017002549A1 (en) Use of a bismuth-thiol (bt) composition, which is used to prepare a medication useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection.
CY2024007I1 (en) GLYCOPYRANOSYL SUBSTITUTED BENZONITRILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS, THEIR USE AND METHODS OF PREPARATION
CL2010000188A1 (en) A method for treating an infection in a subject comprising the administration of 9 - [(2,2-dimethyl-propylamino) -methyl] -minocycline or a salt thereof; pharmaceutical composition comprising said compound; and its use.
CL2017001191A1 (en) Compounds derived from polycyclic carbamoylpyridone; pharmaceutical composition comprising them; and its use for the treatment of a hiv infection in a human who has or is at risk of having the infection.
BR112013011737A2 (en) compound, use of a compound pharmaceutical composition, and method of treating or preventing an HIV infection
CL2012000469A1 (en) Pharmaceutical composition comprising a slowly absorbing insulin conjugate compound; a container; a suspension comprising the composition and its method of preparation; its use for the treatment or prevention of a pathology associated with insulin deficiency, such as diabetes; a kit.
BRPI0910368A2 (en) &#34;use of one or more enhancers chosen from biointensifiers and photo intensifiers, composition for use of one or more enhancers chosen from biointensifiers and photo intensifiers and eye drops for use of one or more intensifiers chosen from biointensifiers and photo intensifiers&#34;
EA200801997A1 (en) NEW CONNECTIONS
EA200970047A1 (en) WATER SUSPENSIONS TMS278
RU2010129238A (en) APPLICATION OF ISOTHIOCYANATE DERIVATIVES AS ANTI-VEHICLES
WO2013052958A3 (en) Antimicrobial compositions and methods employing same
BRPI0814593A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
UY31145A1 (en) DERIVED FROM 17B + CIANO-18A-HOMO-19-NOR-ANDROST-4-ENO, ITS USE AND MEDICATION CONTAINING IT
CR20190006A (en) COMPOSITION AND CONTRIBUTION FOR WOUND TREATMENT
ECSP13012382A (en) SOLID COMPOSITIONS
CL2012002716A1 (en) Use of a dgat1 inhibitor compound because it is useful in the prevention, delay of progress or treatment of a disease or condition selected from chylomicronemia, familial chylomicronemia syndrome and type v hyperlipoproteinemia; a compound derived from substituted heteroaryl; pharmaceutical composition
BRPI0907892A2 (en) Azatricyclic antibiotic compound, medicine, pharmaceutical composition containing and use thereof
CL2012003266A1 (en) Tamarind seed polysaccharide for use in the treatment of microbial infections; pharmaceutical and / or antimicrobial dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide; method to treat and / or prevent a patient who has a microbial infection.
AR077139A1 (en) PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT VCH
BRPI0911772A2 (en) compound, pharmaceutical composition, and use of the compound.
BRPI0720323A2 (en) compound, method of treatment, pharmaceutical composition and use of the compound
BR112012021108A2 (en) biocidal compositions, and use of valerolactone and / or its amide derivatives
UY32408A (en) ANTI-INFLAMMATORY MACROLIDO
BRPI0720684A2 (en) compound, drug, pharmaceutical composition containing and use of compound
CL2009001089A1 (en) Indole-derived compounds [2,1-a] [2] benzacepin; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.